Dear Spiral User, There is still no access to Master’s dissertations until further notice. We apologise for any inconvenience this may cause. Please contact your subject librarian for further assistance. Kind Regards, Spiral Team.
 
Off-label use of bedaquiline in children and adolescents with drug-resistant tuberculosis
File(s)
17-0303.pdf (346.3 KB)
Published version
Author(s)
Achar, J
Hewison, C
Cavalheiro, A
Skrahina, A
Cajazeiro, J
Type
Journal Article
Abstract
Limited information on the use of bedaquiline in children and adolescents has resulted in restriction of its use to adults. This report describes 27 children and adolescents aged <18 years who received bedaquiline during treatment for drug-resistant TB. We report good treatment responses and no cessation due to adverse effects.
Date Issued
2017-10-01
Date Acceptance
2017-06-13
Citation
Emerging Infectious Diseases, 2017, 23 (10), pp.1711-1713
URI
DOI
ISSN
1080-6059
Publisher
Centers for Disease Control and Prevention
Start Page
1711
End Page
1713
Journal / Book Title
Emerging Infectious Diseases
Volume
23
Issue
10
Copyright Statement
All materials published in Emerging Infectious Diseases are in the public domain and can be used without permission. Achar J, Hewison C, Cavalheiro AP, et al. Off-Label Use of Bedaquiline in Children and Adolescents with Multidrug-Resistant Tuberculosis. Emerging Infectious Diseases. 2017;23(10):1711-1713. doi:10.3201/eid2310.170303.
License URL
Subjects
1108 Medical Microbiology
1117 Public Health And Health Services
1103 Clinical Sciences
Microbiology
Publication Status
Published